Can Helicobacter pylori-associated dyspepsia be categorized as functional dyspepsia?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue SUPPL. 3, 2011, Pages 42-45

  Suzuki, Hidekazu ^a   Nishizawa, Toshihiro ^b   Hibi, Toshifumi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

Author keywords

Acid; Asia; Eradication; Functional dyspepsia; Ghrelin; Helicobacter pylori; Meta analysis; MicroRNA

Indexed keywords

AMOXICILLIN; BISMUTH; CLARITHROMYCIN; GASTRIN RELEASING PEPTIDE; GHRELIN; HISTONE DEACETYLASE 4; METRONIDAZOLE; OMEPRAZOLE; PLACEBO; SERUM RESPONSE FACTOR; SUCRALFATE; TETRACYCLINE; TINIDAZOLE;

ACID SECRETION; DYSPEPSIA; ERADICATION THERAPY; FUNCTIONAL DYSPEPSIA; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; META ANALYSIS (TOPIC); MONOTHERAPY; NON ULCER DYSPEPESIA; NONHUMAN; PATHOGENESIS; PEPTIC ULCER; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STOMACH EMPTYING;

EID: 79953096246     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06629.x     Document Type: Review

References (19)

1. Talley NJ, Phillips SF, Melton J, 3rd, Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann. Intern. Med. 1989; 111: 671-4.
2. Thompson WG, Heaton KW. Functional bowel disorders in apparently healthy people. Gastroenterology 1980; 79: 283-8.
3. Suzuki H, Nishizawa T, Hibi T. Helicobacter pylori eradication therapy. Future Microbiol. 2010; 5: 639-48.
4. Suzuki H, Nishizawa T, Hibi T. Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification. J. Gastroenterol. 2006; 41: 513-23.
5. Moss SF, Legon S, Bishop AE, Polak JM, Calam J. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 1992; 340: 930-2.
6. El-Omar E, Penman I, Dorrian CA, Ardill JE, McColl KE. Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut 1993; 34: 1060-5.
7. Nishizawa T, Suzuki H, Nomoto Y etal. Enhanced plasma ghrelin levels in patients with functional dyspepsia. Aliment. Pharmacol. Ther. 2006; 24: 104-10.
8. Saito Y, Suzuki H, Tsugawa H etal. Dysfunctional gastric emptying with down-regulation of muscle-specific microRNAs in Helicobacter pylori-infected mice. Gastroenterology 2011; 140: 189-98.
9. Hall W, Buckley M, Crotty P, O'Morain CA. Gastric mucosal mast cells are increased in Helicobacter pylori-negative functional dyspepsia. Clin. Gastroenterol. Hepatol. 2003; 1: 363-9.
10. McColl K, Murray L, El-Omar E etal. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N. Engl. J. Med. 1998; 339: 1869-74.
11. Blum AL, Talley NJ, O'Morain C etal. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N. Engl. J. Med. 1998; 339: 1875-81.
12. Moayyedi P, Soo S, Deeks J etal. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst. Rev. 2003; 1: CD002096.
13. Laine L, Schoenfeld P, Fennerty MB. Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials. Ann. Intern. Med. 2001; 134: 361-9.
14. Talley NJ, Vakil N, Ballard ED, 2nd, Fennerty MB. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. N. Engl. J. Med. 1999; 341: 1106-11.
15. Moayyedi P, Feltbower R, Brown J etal. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group. Lancet 2000; 355: 1665-9.
16. Moayyedi P, Deeks J, Talley NJ, Delaney B, Forman D. An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews. Am. J. Gastroenterol. 2003; 98: 2621-6.
17. Gwee KA, Teng L, Wong RK, Ho KY, Sutedja DS, Yeoh KG. The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection. Eur. J. Gastroenterol. Hepatol. 2009; 21: 417-24.
18. Dhali GK, Garg PK, Sharma MP. Role of anti-Helicobacter pylori treatment in H. pylori-positive and cytoprotective drugs in H. pylori-negative, non-ulcer dyspepsia: results of a randomized, double-blind, controlled trial in Asian Indians. J. Gastroenterol. Hepatol. 1999; 14: 523-8.
19. Suzuki H, Masaoka T, Sakai G, Ishii H, Hibi T. Improvement of gastrointestinal quality of life scores in cases of Helicobacter pylori-positive functional dyspepsia after successful eradication therapy. J. Gastroenterol. Hepatol. 2005; 20: 1652-60.